Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at [email protected].

  • December 16, 2019

    UsAgainstAlzheimer’s Praises $350 Million Increase for NIH Funding for Alzheimer’s Research

    Continued Growth in Research Funding Amidst Hopeful Signs for Drug Therapies in...

    Read more
  • December 12, 2019

    UsA2 Urges Congress to Finish the Job and Expand Paid Family Leave to Caregivers

    UsAgainstAlzheimer’s issued the following statement on the expanded paid family leave provisions...

    Read more
  • November 20, 2019

    UsAgainstAlzheimer’s Hails Increasing Attention by Congress on Alzheimer’s and Momentum for CHANGE Act

    UsA2 calls for continued action on key priorities for patients, providers and...

    Read more
  • November 14, 2019

    UsAgainstAlzheimer’s Praises House Ways & Means Committee Hearing on Caring for Aging Americans

    Calls for Congress to pass CHANGE Act and improve early detection of...

    Read more
  • November 13, 2019

    Global Alliance on Women’s Brain Health Expands in Europe with New Partnership Launched in Switzerland

    Women’s Brain Project Switzerland joins Be Brain Powerful ® campaigns already...

    Read more
  • November 13, 2019

    UsAgainstAlzheimer’s Launches Online Biomarkers Repository to Track Alzheimer’s Research

    Constantly-evolving Biomarkers Repository to help policymakers, healthcare system leaders and scientific community...

    Read more
  • November 04, 2019

    UsAgainstAlzheimer’s Welcomes China’s Approval of Alzheimer’s Drug Oligomannate

    George Vradenburg, chairman and co-founder of UsAgainstAlzheimer’s, welcomed the announcement by Shanghai Green Valley Pharmaceuticals that Oligomannate had been...

    Read more
  • November 04, 2019

    Niles Godes Joins UsA2 as Chief Government Relations and Policy Officer

    UsAgainstAlzheimer’s today announced Niles Godes, an experienced government policy and advocacy leader...

    Read more
  • October 25, 2019

    Four Leading Alzheimer’s Organizations Agree on Need For National, Time-Based Prevention Goal

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.